Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
41.7%
% of BBH's 26 holdings also in GNOM
25.6%
% of GNOM's 39 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.2% | 7.1% | 5.2% |
|
ALNYLAM PHARMACEUTICALS INC | 4.3% | 4.5% | 4.3% |
|
GILEAD SCIENCES INC | 13.2% | 3.4% | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 12.6% | 3.0% | 3.0% |
 |
BIONTECH SE SPONSORED ADR | 2.8% | 5.1% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to GNOM
|
AMGEN INC | 16.4% |
|
GILEAD SCIENCES INC | 9.8% |
|
VERTEX PHARMACEUTICALS INC | 9.6% |
 |
ARGENX SE ADR | 5.8% |
|
REGENERON PHARMACEUTICALS | 5.2% |
|
IQVIA HOLDINGS INC | 4.0% |
|
BIOGEN IDEC INC | 3.3% |
 |
ICON PLC | 3.2% |
|
INSMED INC | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.2% |
BBH Underweight Relative to GNOM
|
VERACYTE INC | -5.5% |
|
CRISPR THERAPEUTICS AG | -4.7% |
|
AGILENT TECHNOLOGIES INC | -4.4% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -4.2% |
 |
GENSCRIPT BIOTECH CORPORATION | -3.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.7% |
|
AVIDITY BIOSCIENCES INC | -3.3% |
|
BEAM THERAPEUTICS, INC. | -3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.2% |
|
BIOMARIN PHARMACEUTICAL INC | -3.1% |